MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-05-2026
Integra LifeSciences Holdings Corporation Interest Expense 2011-2026 | IART
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.94 M | 3.72 M | 12 M | 50.4 M | 71.6 M | 54 M | 64.7 M | 35 M | 25.8 M | 23.5 M | 22 M | 19.7 M | 22.2 M | 27.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 71.6 M | 3.72 M | 31.2 M |
Quarterly Interest Expense Integra LifeSciences Holdings Corporation
| 2026-Q1 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.48 M | -1.95 M | -144 K | 2.11 M | 1.44 M | -610 K | 471 K | -155 K | 12.1 M | - | 12.8 M | 12.2 M | 11.7 M | - | 12.2 M | 13.1 M | 12.9 M | - | 20.8 M | 15.7 M | 17.8 M | - | 14 M | 13.4 M | 13.1 M | - | 14.5 M | 17.5 M | 18.8 M | - | 6.76 M | 6.18 M | 5.13 M | - | 6.3 M | 6.59 M | 6.37 M | - | 6.46 M | 5.48 M | 5.47 M | - | 5.91 M | 5.38 M | 5.14 M | - | 5.32 M | 4.96 M | 4.8 M | - | 5.55 M | 7.1 M | 7.93 M | - | 7.59 M | 6.72 M | 5.47 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 20.8 M | -1.95 M | 8.11 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K |  USA |
 |
Axonics Modulation Technologies
AXNX
|
624 K | - | - | $ 3.31 B | USA |
 |
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
-146 K | $ 11.2 | 0.27 % | $ 317 M | USA |
 |
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
45.9 M | $ 8.24 | 0.24 % | $ 1.24 B | USA |
 |
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
232 K | $ 4.25 | -1.62 % | $ 159 M |  France |
 |
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
636 K | $ 5.88 | 1.38 % | $ 70.3 M | USA |
 |
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.31 | 6.94 % | $ 50.9 M | USA |
 |
MiMedx Group
MDXG
|
-558 K | $ 3.79 | 4.12 % | $ 560 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 18.5 | 1.48 % | $ 434 M | USA |
 |
LivaNova PLC
LIVN
|
664 K | $ 73.71 | 1.08 % | $ 4.02 B |  Britain |
 |
Delcath Systems
DCTH
|
-70 K | $ 11.23 | 3.5 % | $ 402 M | USA |
 |
Neovasc
NVCN
|
133 K | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
549 K | - | - | $ 10.2 M | USA |
 |
Pulmonx Corporation
LUNG
|
790 K | $ 1.54 | 14.93 % | $ 62.7 M | USA |
 |
Electromed
ELMD
|
455 K | $ 37.74 | -1.64 % | $ 319 M | USA |
 |
Myomo
MYO
|
-668 K | $ 0.91 | 4.17 % | $ 38.1 M | USA |
 |
Butterfly Network
BFLY
|
2.77 M | $ 4.39 | 6.94 % | $ 1.08 B | USA |
 |
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | USA |
 |
Orthofix Medical
OFIX
|
8.11 M | $ 12.15 | 0.5 % | $ 481 M |  Curacao |
 |
Sintx Technologies
SINT
|
31 K | $ 2.21 | 0.45 % | $ 6.13 M | USA |
 |
Profound Medical Corp.
PROF
|
146 K | $ 6.92 | 2.82 % | $ 209 M | Canada |
 |
Globus Medical
GMED
|
3.41 M | $ 84.03 | 5.13 % | $ 11.4 B | USA |
 |
Insulet Corporation
PODD
|
14.3 M | $ 156.59 | 1.28 % | $ 11 B | USA |
 |
CONMED Corporation
CNMD
|
31.1 M | $ 37.01 | 2.29 % | $ 1.15 B | USA |
 |
Inspire Medical Systems
INSP
|
-2.66 M | $ 44.14 | 3.79 % | $ 1.3 B | USA |
 |
TransMedics Group
TMDX
|
3.87 M | $ 68.0 | 2.83 % | $ 2.31 B | USA |
 |
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 91.49 | 1.16 % | $ 3.18 B | USA |
 |
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 82.97 | 0.99 % | $ 48.5 B | USA |